Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.07 | 0.8 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |